Company Filing History:
Years Active: 2010-2025
Title: Inventor Spotlight: Stefan Mallmann
Introduction
Stefan Mallmann is a notable inventor based in Heidesheim, Germany, recognized for his contributions to the pharmaceutical industry. With a strong focus on improving the formulation and efficacy of pharmaceutical preparations, Mallmann has secured a total of two innovative patents.
Latest Patents
One of Stefan Mallmann's latest patents pertains to the use of dicalcium phosphate anhydride powder, particularly formulated for direct tableting or capsule filling of pharmaceutical preparations. The dicalcium phosphate anhydride powder of his invention has specific requirements: at least 50% by weight falls within a grain size of 45 to 150 µm, while a maximum of 50% weighs less than 45 µm, and the remainder accounts for up to 5% with a grain size exceeding 150 µm. Additionally, this powder presents a bulk density ranging from 1000 to 1500 g/l and a specific surface area of less than 5 m²/g.
Another patent by Mallmann emphasizes similar attributes of dicalcium phosphate anhydride powder, underscoring its potential for pharmaceutical applications. This formulation not only maintains a particle distribution similar to his first patent but also extends the bulk density specification to heights reaching 5000 g/l, while still retaining a specific surface area of under 5 m²/g. This innovation seeks to enhance the direct tableting and encapsulation processes within the pharmaceutical sector.
Career Highlights
Stefan Mallmann is associated with Chemische Fabrik Budenheim KG, a leading company in the field of chemical products. His work here emphasizes the development and optimization of pharmaceutical ingredients, which significantly contribute to the potency and reliability of medications.
Collaborations
In his endeavors at Chemische Fabrik Budenheim, Mallmann collaborates with industry experts like Erhard Fischer and Gerhard Scheuer. Their combined efforts facilitate the advancement and successful implementation of novel inventions in pharmaceutical formulations.
Conclusion
Through his innovative patents and collaborative work, Stefan Mallmann is shaping the future of pharmaceutical preparations, ensuring that the industry continues to develop effective and efficient solutions for health-related challenges. His contributions exemplify the critical intersection of chemistry and health, showcasing the ongoing importance of innovation in the pharmaceutical field.